048410.KQ

Hyundai Bioscience Co., Ltd. [048410.KQ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

048410.KQ Stock Summary

Top 10 Correlated ETFs

048410.KQ

Top 10 Correlated Stocks

048410.KQ

In the News

048410.KQ Financial details

Company Rating
-
Market Cap
791.59B
Income
-14.5B
Revenue
9.48B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
63
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-52.97
Forward P/E
-
PEG
57.28
P/S
92.98
P/B
17.43
P/C
-
P/FCF
-85.33
Quick Ratio
2.17
Current Ratio
2.59
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-364.4
EPS next Y
-
EPS next Q
-
EPS this Y
-9.21%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-20.62%
Revenue Q/Q
-42.25%
EPS Q/Q
308.55%
-
-
-
-
SMA20
-4.87%
SMA50
-6.87%
SMA100
-3.07%
Inst Own
-
Inst Trans
-
ROA
-29%
ROE
-31%
ROC
-0.32%
Gross Margin
53%
Oper. Margin
-170%
Profit Margin
-175%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
17600.0-41200.0
52W High
-87.31%
52W Low
-70.28%
RSI
41.2
Rel Volume
0.7
Avg Volume
466.01K
Volume
324.4K
Perf Week
-1.32%
Perf Month
-9.67%
Perf Quarter
-3.77%
Perf Half Y
-5.25%
-
-
-
-
Beta
1.171
-
-
Volatility
82.93%, 166.95%
Prev Close
-1.13%
Price
5230
Change
-3.15%

Something similar

Top by Market Cap
MIX.JO
MSF.DE
VTSAX
FXAIX
AAPL
Top Correlated ETFs
217780.KS
136340.KS
300640.KS
215620.KS
Top Correlated Stocks
215600.KQ
243070.KQ
011690.KS
002720.KS
083420.KS
Similar Market Cap
7261.T
2318.HK
9042.T
BEST.JK
2327.T

Company Profile

Healthcare Medical - Pharmaceuticals

Hyundai Bioscience Co., Ltd., a biotechnology company, develops and commercializes bio-fusion technology for delivering active ingredients to human body. The company provides Vitabrid C12, a new-conceptual vitamin C product that delivers active vitamin C into the skin. It also develops organic-inorganic hybrid technology, a drug delivery system technology that allows the selective and effective delivery of active substances on the target area in combination with bio-friendly minerals, as well as in anticancer drug carrier technology. The company was founded in 2000 and is based in Seoul, South Korea.